Key terms
About HSDT
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HSDT news
Apr 15
5:23pm ET
Helius Medical files to sell Class A common stock, warrants, no amount given
Apr 03
2:09pm ET
Shares of Helius Medical pop 10% after PoNS Therapy partnership with Lovell
Apr 03
7:18am ET
Helius Medical expands reach of PoNS Therapy with Lovel Government Services
Apr 02
7:36am ET
Helius Medical Technologies (HSDT) Gets a Buy from Maxim Group
Mar 28
4:26pm ET
Helius Medical reports Q4 EPS ($1.47), consensus ($3.77)
Mar 12
9:01am ET
Helius Medical initiates open-label study for registrational program in stroke
Mar 05
12:54pm ET
Helius Medical price target raised to $24 from $5 at Roth MKM
Mar 04
7:12am ET
Helius Medical secures HCPCS codes for PoNS
Feb 10
4:35am ET
Helius Medical Technologies Boosts Finance with Stock Sales
Feb 06
9:48am ET
Helius Medical Technologies Inc trading resumes
Feb 06
9:43am ET
Helius Medical Technologies Inc trading halted, volatility trading pause
Feb 06
7:05am ET
Helius Medical announces alignment with FDA on registrational program
Feb 05
7:14am ET
Helius Medical expands presence at 2025 APTA CSM
HSDT Financials
Key terms
Ad Feedback
HSDT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HSDT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range